Catalyst Wire Dossier Catalyst Wire Dossier

BI 474121

· Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for BI 474121, covering 2024-03-07 to 2024-03-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study in Healthy Men to Test How the Body Takes up and Tolerates Different Doses of BI 474121, and Whether it Makes a Difference if BI 474121 is Taken as a Tablet or a Drink. [Phase 1]

See pricing